Group name
Neoadjuvant HT Group
Age
68 (52–77)
Age remark
median (IQR)
PSA
7.45 (4.2-49.3)
PSA remark
Initial PSA (ng/mL)
low
9 (14.5%)
intermediate
23 (37.1%)
high
30 (48.4%)
Risk remark
D’Amico risk classification